News

A study led by clinician-scientists and researchers at the National Cancer Centre Singapore (NCCS) has found that the tumor ...
One of the primary nasopharyngeal cancer causes is infection with the Epstein-Barr virus (EBV), which may alter the DNA of cells in the nasopharynx, leading to uncontrolled growth.
Smoking, alcohol consumption and betel nut chewing are some of the lifestyle factors that have been linked to head and neck ...
Landmark study uncovers role of tumour microenvironment in nasopharyngeal carcinoma progression which supports personalised treatment Molecular ...
The Institute has a strong pedigree in understanding the fundamental mechanisms that underpin the success of vaccination and in the development of novel vaccines and their mode of action.
13.06.2025 13:25 Chronic Bile Duct Inflammation Linked to Epstein-Barr Virus Reactivation Frederike Buhse Presse- und Öffentlichkeitsarbeit Exzellenzcluster Präzisionsmedizin für chronische ...
Merck & Co has entered into a worldwide licensing deal with Opko Health’s ModeX Therapeutics unit for a vaccine candidate against Epstein-Barr virus (EBV) that could be worth up to $922.5 ...
Dr. Mallika Marshall has more on both stories in this edition of Healthwatch. Musk jokes about reconsidering stance on Big Beautiful Bill after Schiff's praise John Wick Boss Slams Spin-Off Series ...
R9AP is a key receptor for entry of Epstein–Barr virus into human epithelial and B cells, and interacts directly with the viral glycoprotein gH/gL complex to mediate virus–host membrane fusion.